1、Dai L, Gu L, Ding C, Qiu L#, Di W. . TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.. Cancer Lett.,2009;283（2）:159-167
2、Yang H, Qiu L*, Di W, Zhao A, Chen G, Hu K, Lin Q. . Proportional change of CD4(+)CD25(+) regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients.. Fertil Steril.,2009;92(1):301-5.
3、Yang H, Qiu L*, Chen G, Ye Z, Lü C, Lin Q. . Proportional change of CD4(+)CD25(+) regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. . Fertil Steril.,2008;89(3):656-661.
4、Qiu L*, Zhou C, Sun Y, Di W, Scheffler E, Healey S, Wanebo H, Kouttab N, Chu W, Wan Y. . Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. . Oncol Rep.,2006;16(4):907-13.
5、Qiu L*, Zhou C, Sun Y, Di W, Scheffler E, Healey S, Kouttab N, Chu W, Wan Y.. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.. Int J Oncol.,2006;29(4):1003-11
6、Qiu L*, Di W, Jiang Q, Scheffler E, Derby S, Yang J, Kouttab N, Wanebo H, Yan B, Wan Y. . Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.. Int J Oncol.,2005;27(5):1441-1448
7、Qiu L*, Wang Q, Di W, Jiang Q, Schefeller E, Derby S, Wanebo H, Yan B, Wan Y. . Transient activation of EGFR/AKT cell survival pathway and expression of surviving contribute to reduced sensitivity of human melanoma cells to betulinic acid. . Int J Oncol.,2005;27(3): 823-30
|
